Related references
Note: Only part of the references are listed.Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial
Ali Belkouz et al.
BRITISH JOURNAL OF CANCER (2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Vivek Subbiah et al.
LANCET ONCOLOGY (2020)
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
Siddhartha Yadav et al.
EJSO (2019)
Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.
Zev A. Wainberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
Maria Maddalena Simile et al.
MEDICINA-LITHUANIA (2019)
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study
Jean-Marc Phelip et al.
DIGESTIVE AND LIVER DISEASE (2019)
Neoadjuvant Treatment for Pancreatic Cancer
Alexander G. Raufi et al.
SEMINARS IN ONCOLOGY (2019)
Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
T. Ebata et al.
BRITISH JOURNAL OF SURGERY (2018)
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
Tatsuaki Sumiyoshi et al.
WORLD JOURNAL OF SURGERY (2018)
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
B. Le Roy et al.
BRITISH JOURNAL OF SURGERY (2018)
Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.
Julien Edeline et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
Jang Han Jung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Recurrence after resection with curative intent for distal cholangiocarcinoma
K. Komaya et al.
BRITISH JOURNAL OF SURGERY (2017)
Next-Generation Sequencing Survey of Biliary Tract Cancer Reveals the Association Between Tumor Somatic Variants and Chemotherapy Resistance
Daniel H. Ahn et al.
CANCER (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Neoadjuvant chemoradiation therapy for cholangiocarcinoma to improve R0 resection rate: The first report of phase II study.
Yu Katayose et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development
Yasuni Nakanuma et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Surgical Resection after Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer: A Retrospective Single-center Study
Atsushi Kato et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis
Samdeep Mouli et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
Young-Il Kim et al.
RADIATION ONCOLOGY (2013)
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival
Ralf-T. Hoffmann et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
Sarwa Darwish Murad et al.
GASTROENTEROLOGY (2012)
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan et al.
GUT (2012)
Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success
Thomas J. Vogl et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients
Yi-Xing Chen et al.
BMC CANCER (2010)
Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma
A. Kobayashi et al.
BRITISH JOURNAL OF SURGERY (2010)
Liver transplantation for cholangiocarcinoma
Charles B. Rosen et al.
TRANSPLANT INTERNATIONAL (2010)
CONCURRENT CHEMORADIOTHERAPY IN RESECTED EXTRAHEPATIC CHOLANGIOCARCINOMA
John W. Nelson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma:: a prospective multicentre phase II trial
O. Nehls et al.
BRITISH JOURNAL OF CANCER (2008)
Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma
K. Shitara et al.
CLINICAL ONCOLOGY (2008)
Prospective phase II trial of Neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head
Stefan Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Surgery for cholangiocarcinoma: the role of liver transplantation
C. B. Rosen et al.
HPB (2008)
Transarterial Chemoembolization (TACE) for inoperable intrahepatic Cholangiocarcinoma
S. Herber et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine alone versus gemcitabine combined with cisplatin
Daniel H. Palmer et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma
Julie K. Heimbach et al.
TRANSPLANTATION (2006)
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma - Palliative photodynamic therapy plus stenting is comparable to R1/R2 resection
Helmut Witzigmann et al.
ANNALS OF SURGERY (2006)
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma
DJ Rea et al.
ANNALS OF SURGERY (2005)
Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma -: A phase II pilot study
M Wiedmann et al.
CANCER (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy
MF Gerhards et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)
Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma
I De Vreede et al.
LIVER TRANSPLANTATION (2000)
Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma
F Berr et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
